Danny Rischin - Researcher Profile | RDL Research Database

Publications

2 shown

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness , Kevin J. Harrington , Richard Greil +97 more

2019 The Lancet 2928 citations

Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer

Masahiro Fukuoka , Seiji Yano , Giuseppe Giaccone +17 more

Purpose: To evaluate the efficacy and tolerability of two doses of gefitinib (Iressa [ZD1839]; AstraZeneca, Wilmington, DE), a novel epidermal growth factor receptor tyrosine ki...

2003 Journal of Clinical Oncology 2877 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 3
Citations: 8,733
Institution: Universitair Ziekenhuis Leuven

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-3368-0386

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.